Colgate-Palmolive Company (CL) has been in the spotlight of late, attracting the interest of investors and finance analysts alike. Despite underperforming compared to competitors on individual trading days, the company reported an impressive 40% rise in its stock. Amid strong institutional backing, hedge funds like Farther Finance Advisors and Mutual Advisors LLC started progressively increasing their position in this company. CL's strong organic sales growth and beats on Q3 earnings and revenue estimates have contributed to raising optimism. Their Q3 sales are inline with estimates, and they've elevated their 2024 outlook following market share gains and margin expansion. In terms of strategy, SWOT insight into the company reveals formidable underlying fundamentals, although future growth opportunities present some challenges. Despite some setbacks, notably in North American sales, the company lifted its lower end of 2024 results forecast based on steady demand. CL's ability to exceed earnings estimations alongside a strong earnings growth rate signifies an opportunity for growth-conscious investors. Despite a recent downgrade to 'Hold' by Stifel, it remains a Morgan Stanley high-conviction stock and receives an average recommendation of 'Moderate Buy' from brokerages.
Colgate-Palmolive Company CL News Analytics from Wed, 01 May 2024 07:00:00 GMT to Sat, 02 Nov 2024 12:30:25 GMT -
Rating 5
- Innovation 4
- Information 8
- Rumor 5
